Literature DB >> 7748692

Cholestatic jaundice and congenital hypopituitarism.

C J Ellaway1, M Silinik, C T Cowell, K J Gaskin, K R Kamath, S Dorney, K C Donaghue.   

Abstract

OBJECTIVE: The prevalence of cholestatic jaundice as a presenting feature of congenital hypopituitarism is assessed.
METHODOLOGY: A retrospective case record analysis of the presenting features in all patients diagnosed as having congenital hypopituitarism between 1973-93.
RESULTS: Seven of the 20 patients with congenital hypopituitarism presented with cholestatic jaundice as the major initial manifestation of the disorder. Liver biopsy findings in three revealed intracellular bile pigment accumulation and variable giant cell formation.
CONCLUSION: Cholestatic jaundice was the major manifestation of congenital hypopituitarism in 35% of patients presenting in the neonatal or early infancy period.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7748692     DOI: 10.1111/j.1440-1754.1995.tb02914.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  10 in total

1.  Liver dysfunction associated with congenital hypopituitarism.

Authors:  T Arrigo; M Wasniewska; L Ghizzoni; M F Messina; G Crisafulli; F De Luca
Journal:  J Endocrinol Invest       Date:  2000-03       Impact factor: 4.256

Review 2.  Hypopituitarism Related Cholestatic Jaundice: Important to Recognise, Rewarding to Treat but Difficult to Diagnose!

Authors:  Rishi Bolia; Anshu Srivastava
Journal:  Indian J Pediatr       Date:  2019-03-13       Impact factor: 1.967

3.  Congenital adenohypophysis aplasia: clinical features and analysis of the transcriptional factors for embryonic pituitary development.

Authors:  T Arrigo; M Wasniewska; F De Luca; M Valenzise; F Lombardo; D Vivenza; T Vaccaro; E Coradi; A Biason-Lauber
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

4.  Dose Adjustments of Hydrocortisone and L-thyroxine in Hypopituitarism Associated with Cholestasis.

Authors:  Asako Higuchi; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2006-08-02

5.  Cholestasis caused by panhypopituitarism and acquired cytomegalovirus infection in a 2-month-old male infant: A case report.

Authors:  U Chan; Wai-Tao Chan; Wei-Hsin Ting; Che-Sheng Ho; Hsi-Che Liu; Hung-Chang Lee
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

6.  Genetic causes of hypopituitarism.

Authors:  Katherine Parkin; Ritika Kapoor; Ravindra Bhat; Anne Greenough
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

7.  Novel Melano-Cortin-2-Receptor Gene Mutation Presenting With Infantile Cholestasis: A Case Report.

Authors:  Abdulaziz Alsaedi; Naglaa M Kamal; Ayman Bakkar; Enad Althobaiti; Muhammad Naeem; Mohamed Kamal
Journal:  Clin Med Insights Case Rep       Date:  2022-04-08

8.  Isolated cortisol deficiency: a rare cause of neonatal cholestasis.

Authors:  Abdulrahman Al-Hussaini; Awatif Almutairi; Alaaddin Mursi; Mohammed Alghofely; Ali Asery
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485

9.  Cholestasis Reveals Severe Cortisol Deficiency in Neonatal Pituitary Stalk Interruption Syndrome.

Authors:  Francois-Xavier Mauvais; Emmanuel Gonzales; Anne Davit-Spraul; Emmanuel Jacquemin; Raja Brauner
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

Review 10.  Hypothalamus-Pituitary-Adrenal Dysfunction in Cholestatic Liver Disease.

Authors:  Anca D Petrescu; Jessica Kain; Victoria Liere; Trace Heavener; Sharon DeMorrow
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-12       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.